Description

ITRASPORAX 200 CAP is a high-strength antifungal capsule formulated with Itraconazole 200 mg, belonging to the triazole class of antifungals. It is indicated for the treatment of both superficial fungal infections like onychomycosis and dermatophytosis, as well as systemic mycoses such as aspergillosis, histoplasmosis, and blastomycosis.

Itraconazole inhibits fungal cytochrome P450 enzymes, disrupting the synthesis of ergosterol, an essential component of fungal cell membranes. This leads to the weakening and eventual destruction of the fungal cell.

With its high oral bioavailability and excellent tissue penetration, ITRASPORAX 200 CAP is suitable for pulse dosing or continuous antifungal therapy, particularly in moderate to severe fungal infections. The 200 mg dosage is also beneficial in reducing the frequency of dosing in long-term treatment regimens.

Manufactured in WHO-GMP and ISO-certified facilities, this product is represented by BLUEPILL EXPRESS, a global pharmaceutical exporter known for quality, regulatory compliance, and international logistics. The product is distributed in markets across Asia, Africa, Latin America, the Middle East, and Europe, and is available with full documentation for registration and trade.